Several immune checkpoint proteins, such as programmed cell death protein 1 (PD-1), programmed cell death ligand 1 (PD-L1), and cytotoxic T lymphocyte-associated protein 4 (CTLA-4), enable peripheral immune tolerance under physiological conditions although often become coopted in the cancer context. This evidence concerns the gene CD274 and cancer.